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Multiple lineage-specific surface molecules have recently been defined on human 
T  lymphocytes. Although some of these appear during late intrathymic ontogeny and 
are  maintained  on  all  peripheral  T  cells  (T3),  others  (T4,  TS)  arise  earlier  in 
differentiation and are selectively expressed on functional subpopulations of human 
T  lymphocytes (1-3). In the case of the 20,000-mol wt T3 surface molecule, both its 
appearance  in  intrathymic  ontogeny  at  the  time  of  acquisition  of immunologic 
competence (1, 4) and its critical role in T  lymphocyte function suggested that it was 
closely linked to a recognition receptor for antigen. Thus, antibodies directed against 
T3 were  able  to block both  the  induction  and  the  effector phase  of cell-mediated 
lympholysis, inhibit T  lymphocyte proliferative responses to soluble antigen, and be 
mitogenic for T  lymphocytes (5-8). 
Anti-T4 and anti-T8 monoclonals also blocked cell-mediated lympholysis (CML) 1 
(9,  10). However, whereas anti-T3 inhibited all cytolytic effector clones, anti-T4 and 
anti-T8 selectively abrogated killing of T4  + or T8  + cytotoxic T  lymphocytes (CTL), 
and this inhibition occurred on the level of target cell recognition and/or binding (8, 
11).  Moreover, unlike T3,  they did  not  inhibit  antigen-induced proliferation.  Fur- 
thermore,  the  correlation  of  T4  and  T8  surface  expression  on  CTL  cells  with 
differential recognition of class II vs. class I molecules on target cells,  respectively (9, 
12), implied that these T  cell surface structures might be functioning in associative 
recognition. 
Given  that  T  lymphocytes recognize antigen  in  a  precise  fashion  (13-17),  there 
must exist,  in addition, discriminative surface recognition structures that are unique 
to individual antigen-responsive T  cell clones (clonotypic). To delineate such mole- 
cules,  we  produced  monoelonal  antibodies  in  the  present  study  against  a  human 
cytolytic T  cell clone, CTSm (target specificity: HLA-A3), and developed a screening 
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strategy  to  select  for  anti-clonotypic antibodies.  In  the  results  reported  below,  we 
describe two such antibodies that block both the specific cytotoxic effector function 
and antigen-induced  proliferation of CT8m. The molecules defined by anti-clonotypic 
antibodies are linked to the T3 surface structure but, in contrast to T3, they detect 
two associated glycoproteins of apparent molecular weights 49,000 and 43,000. 
Materials and Methods 
Derivation of Lymphocyte Populations.  Lymphocytes were obtained by Ficoll-Hypaque density 
centrifugation of blood from a  healthy donor. Epstein-Barr virus (EBV)-transformed B cell 
lines were kindly provided by Dr. Herbert Lazarus (Sidney Farber Cancer Institute). 
Interleukin  2  (IL-2).  IL-2-containing supernatants were  produced  by stimulating whole 
peripheral blood mononuclear  cells with phytohemagglutinin  and phorbol myristate acetate in 
the presence of irradiated Laz 156 cells as described (9). 
Generation and Culture of  Human T Cell Clones.  All T cell clones used in this study were derived 
from a single individual's mononuclear cells stimulated in mixed lymphocyte cultures (MLC) 
with the allogeneic EBV-transformed lymphoblastoid cell line, Laz 156. Cloning and recloning 
were performed as described (9). Several alloreactive human T cell clones (CTSE-tv, CT4I, and 
CT4n)  were  grown  in continuous culture for  >15  mo,  maintaining initial phenotype and 
functions. Optimal  growth  of T  cell  clones was  obtained in  the  presence of a  feeder  cell 
suspension (irradiated autologous peripheral blood mononuclear cells plus irradiated Laz  156 
cells) in IL-2-conditioned media, although proliferation also occurred in the presence of either 
irradiated Laz 156 or IL-2-conditioned medium. 
Cytotoxic T Cell Clone CT8m.  The cytotoxic T cell clone CT8III used in the present study was 
generated  and propagated  in culture as  described  above  (9). The  phenotype of CT8m as 
determined with a panel of monoclonal antibodies by means of indirect immunofluorescence 
was  TI-,T3+,T4-,T6-,TS+,TI  1+,T12+,Ia +.  The  target  specificity as analyzed on a  panel of 
HLA-typed target cells was HLA-A3. Moreover, the cytotoxic effector function of CT8m could 
be blocked by anti-HLA but not by anti-Ia antibodies on the target cell level. 
Production and Characterization of Monoclonal Antibodies.  Monoclonal antibodies anti-T3A, anti- 
T4A, anti-T6, anti-TSA_c, and anti-T12 were produced as previously described (5,  10,  18) and 
used  in  ascites  form.  Monoclonal antibodies directed  at  human  Ia-like  antigens and  flz- 
microglobulin  have been described (19). To produce clonotypic antibodies, BALB/cJ mice were 
initially immunized intraperitoneally  with 5 ×  106 CT8m cells in phosphate-buffered saline. 10 
d  later, a  booster injection with 5 ×  106 CT8m cells i.p.  was performed. 3 d  before somatic 
fusion of immune splenocytes with NS-1 myeloma cells, two mice were injected intravenously 
and intraperitoneally  with a total of 5 ×  106 CTSni cells. After the animals were killed, immune 
splenocytes were  obtained and  fusion was  performed  as  previously described  (5,  10,  18). 
Hybridoma growth was evident by 2 wk, and supernatants of hybridoma clones were subse- 
quently  screened for reactivity on CT8m by means of indirect immunofluorescence.  Hybridomas 
that failed to produce antibodies reactive with CT8In were discarded. Reactive supernatants 
were  then screened on a  large panel of cell  types.  These included autologous and allogeneic 
resting peripheral  blood  cells  (T  cells,  B  cells,  macrophages,  granulocytes,  and  platelets); 
thymocytes; autologous and allogeneic activated T cells (mixed leukocyte reaction lymphohlasts, 
concanavalin A [Con A] lymphoblasts, T cell lines [2-4 mo old]); autologous and allogeneic B 
cell lines (Laz 509, Laz  156, and Laz 471); T  cell tumor lines (CEM, Molt 4, and HSB); and 
tumor lines of non-T cell lineage (K562,  HL-60, Laz 221, and KG1). Hybridomas producing 
antibody of interest were then cloned by limiting  dilution, and individual hybrids were injected 
into pristine-rimed BALB/cJ mice. The resulting ascitic fluid was used as a source of antibody. 
Phenotypic Analysis of T  Cell Surface Antigens.  Phenotype analysis of T  lymphocytes was 
performed by means of indirect immunotluorescence with a  panel of monoclonal antibodies 
and goat anti-mouse F(ab')2 fluorescein isothioeyanate [FITC] on an Epics V cell sorter (Coulter 
Electronics Inc., Hialeah, FL) (9). Quantitative histogram comparisons were performed with a 
Coulter Easy System lmmunoprogram on the basis of mean channel fluorescence. 
Modulation of Surface Antigens by  Monoclonal Antibodies.  CT8m  cells  at  1  ×  106/ml  were 
incubated with saturating amounts of one or another monoclonal antibody for 18 h at 37°C in MEUER  ET AL.  707 
final culture medium RPMI  1640  plus  12% human AB serum.  Subsequently, the cells were 
washed three times and analyzed for expression of various cell surface antigens by means of 
indirect immunofluorescence on a  fluorescence-activated cell sorter (FACS) before assessment 
of their functional properties (5,  1  i). 
Competitive Antibody Binding Inhibition Studies.  For these studies, directly FITC-labeled, puri- 
fied monoclonal antibodies (anti-T3A, anti-TixA, and anti-TilB) were prepared. All experiments 
were performed at 4°C to prevent modulation of cell surface antigens. In the first incubation 
step,  CTSm  cells  were  incubated  with  saturating  amounts  of one  or  another  unlabeled 
monoclonal antibody for 30 min. Then the cells were washed twice and incubated with directly 
FITC-labeled monoclonal antibody (30 min) before FACS analysis. 
Investigation of Cell-Mediated Lympholysis.  To examine functional effects of monoclonal anti- 
bodies to T  cell surface antigens on the cytotoxic effector function, clones were incubated for 
various periods (30 rain-18 h) with monoclonal antibodies at several dilutions or medium prior 
to addition of 51Cr-labeled targets. These experiments were performed at an  effector/target 
(E/T) ratio of 20:1  in V-bottomed microtiter plates (Falcon Labware, Oxnard, CA) according 
to a standard method (20). 
Proliferative Studies.  To investigate the effects of monoclonai antibody treatment on prolif- 
erative capacities, CT8m cells were incubated for various periods (30 rain-18 h) with monoclonal 
antibodies at several dilutions or media. Subsequently, untreated or antibody-treated cells were 
plated at  15,000  cells/well into round-bottomed microtiter plates (Costar, Data  Packaging, 
Cambridge, MA) along with either medium (RPMI 1640 supplemented with 10% human AB 
serum), irradiated Laz 156 cells (15,000 cells/well), IL-2-conditioned medium (final concentra- 
tion 5%), or Laz 156 cells plus IL-2. After a 24-h incubation at 37°C, the various cultures were 
pulsed with 0.2/~Ci of tritiated thymidine ([3H]TdR)  (Schwarz/Mann, Div. Becton Dickinson 
& Co., Orangeburg, NY) and harvested 18 h later on a Mash II apparatus (M. A. Bioproducts, 
Walkersville, MD).  [nH]TdR  incorporation  was  then  measured  in  a  scintillation counter 
(Packard  Instrument  Co.,  Inc.,  Downers  Grove,  IL).  Each  value  represents  the  mean  of 
triplicates. 
Radiolabeling and Immunoprecipitation of T Cell Surface Antigens.  Cell surface iodination of T cell 
131  clones was performed with  Na  I  (New  England  Nuclear,  Boston,  MA)  and  catalyzed by 
lactoperoxidase. To 20 ×  l0  s cells suspended in 1 ml PBS were added successively 10 lal glucose 
(0.5 mol/liter), 5 pl NaI (5 ×  104 tool/liter), 10/~1 lactoperoxidase (2 mg/ml),  1 mCi Na 131I, 
and  20  pl  glucose oxidase (7.5  mU/ml).  This  mixture was  incubated  for  15  rain  at  room 
temperature followed by addition of 100/~1 NaI  (1  mol/liter). After an additional 2  min of 
incubation, cells were washed four times in Hanks' balanced salt solution. The final pellet was 
lysed in 500 pl 1:5 diluted radioimmmune precipitation assay (RIPA) stock solution containing 
1% Triton X-100 (RIPA stock solution: 0.1  mol/liter NaHuPO4,  1 mmol/liter phenylmethyl- 
sulfonyl fluoride, 10 mmol/liter EDTA, 10 mmol/liter EGTA, 10 mMol NaF, 1% deoxycholate 
sodium salt, 200  KIU/ml aprotinin, pH  7.2).  The suspension was centrifuged for 5  rain at 
1,120 g and the resulting supernatant was precleared twice using monoclonal antibody anti-T6 
covalently  linked  to  CnBr-activated  Sepharose  4B  (Pharmacia  Fine  Chemicals,  Uppsala, 
Sweden), each for 60 min at 4°C, and subsequently centrifuged 5 min at  1,120 g. Precleared 
lysates were incubated with monoclonal antibodies bound to CnBr-activated Sepharose 4B for 
2 h  at 4°C.  The resulting precipitate was subsequently washed five times in RIPA solution 
(stock 1:10 diluted) plus 1% Triton X-100 resuspended in gel buffer (0.125  tool/liter Tris-HCl, 
pH 6.8, containing 10% glycerol, 3% sodium dodecyl sulfate [SDS], and 5% 2-mercaptoethanol) 
and boiled for 5 rain. SDS polyacrylamide gel electrophoresis (PAGE) was performed on  a 
continuous vertical slab gel (12.5% polyacrylamide) for 14 h according to a modification of the 
Laemmli procedure (21). 
Results 
To produce monoclonal antibodies to clonally restricted antigen recognition struc- 
tures  on  human  T  lymphocytes, BALB/cJ  mice were  immunized  with  the  human 
cytotoxic  T  cell  clone  CT8m  (phenotype:  TI-,T3+,T4-,T6-,T8+,TII+,T12+,Ia+), 
which  was  previously shown  to  be specific for the  HLA-A3 antigen.  Subsequently, 708  HUMAN T  CELL RECEPTORS FOR ANTIGEN 
Fl~.  1.  Cell  surface expression of TilA and Tim on CTL clones. CT8III (panel A) or CT8tv (panel 
B) cells were analyzed by means of indirect immunofluorescence  with goat anti-mouse F(ab')2-FITC 
and the following  monoclonal antibodies: anti-T6, I:500 (negative control [  ]); anti-TilA, 1:500, 
anti-Tim,  1:500 ( ....... ); anti-T3B, 1:500 (shaded area). CT8Iv is representative of a panel of 80 
alloreactive TiaA- and Tim-negative T cell colonies derived from the same donor as CT8m. 
immune  splenocytes  were  fused  with  the  NS-1  mouse  myeloma  line  by  standard 
hybridization technique (3). Of 221 individual hybridoma clones that were established 
in hypoxanthine, aminopterin, thymidine medium, 59 secreted monoclonal antibodies 
reactive with  the immunizing clone CT8In.  However, 43 of these 59 antibodies  were 
also  reactive  with  the  autologous  B  lymphoblastoid  cell  line  Laz  509  and  were 
therefore most likely directed  at  either alloantigens  or other broadly distributed  cell 
surface  molecules.  In  contrast,  the  remaining  16  antibodies  were  reactive  with  the 
immunizing  clone  but  lacked  reactivity  with  B  cells,  macrophages,  granulocytes, 
platelets,  B  lymphoblastoid  lines,  myeloid  lines,  and  other  hematopoietic  lines  (see 
Materials and Methods). 
Within the latter group, seven antibodies  were reactive with the  76KD T8 surface 
structure (anti-T8D_a), one recognized the 20,000-tool wt T3 molecule (anti-T3B), and 
six were specific for activated but not resting T  lymphocytes (anti-TAl_6). In addition, 
two antibodies,  termed  anti-TilA  and  anti-TiaB,  reacted  exclusively  with  the  CTSIn 
clone and were of the IgG1 and IgM isotype, respectively. 
Unlike the other  14 antibodies,  anti-TilA and anti-TilB  did not react with human 
thymocytes  or  resting  or  activated  human  peripheral  T  cells  (both  autologous  or 
allogeneic).  More  importantly,  these  were also nonreactive  with  80  additional  indi- 
vidual alloreactive T  cell clones derived from the same donor as CT8In. The pattern 
of  antibody  binding  to  the  alloreactive  TilA+TilB+  clone  CT8nI,  and  CTSIv,  a 
representative  TilA-Tim-  clone,  is  shown  in  Fig.  1.  All  CT8nI  cells  (panel  A)  are 
reactive with anti-TilA and anti-TiaB, whereas CTSIv cells are nonreactive with either 
antibody as analyzed by indirect  immunofluorescence on an  Epics  V  cell  sorter.  In 
contrast, both CT8xlt and CT8Iv express the 20,000-mol wt T3 molecule as defined by 
anti-T3  reactivity  (shaded  area).  Similar  results  to those obtained  with  CTSIv were 
found for the other 79 autologous clones. 
Given the unique reactivities of anti-TilA and anti-Tim monoclonal antibodies with MEUER ET AL.  709 
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Fro.  2.  Influence of various monoclonal antibodies on CML function of  T cell clone CT8m. CT8m 
cells were incubated with various monoclonal antibodies or media before assessment of  their cytolytic 
activity directed at 5XCr-labeled Laz 156 target cells. Final dilutions of monoclonal antibodies: anti- 
T3A, 1:300; anti-T3B, 1:500; anti-TixA, 1:300; anti-Tim,  1:500; anti-TSA, 1:500; anti-TSc,  1:500; 
anti-T12,  1:500. The E/T ratio was 20:1. Numbers give percent specific lysis and represent the 
means of triplicates (SD _< 10% of maximal lysis). 
the  antigen-specific  cytotoxic  T  cell  clone  CTSm,  it  was  important  to  determine 
whether the surface structures that they defined were involved in antigen recognition. 
To  this  end,  anti-TitA  and  anti-Tim  were  incubated  with  CT8IN cells  for  various 
periods  before assay of the clone's cytolytic and proliferative  capacities.  In parallel, 
the  effects  of several  other  T  cell-specific  monoelonal  antibodies  (anti-T3A,  -T3B, 
-T8A, -T8c, and -T12) were investigated. As shown in Fig. 2, at an E/T ratio of 20:1, 
CTSm  cells  were  highly  efficient  (>50%  specific  lysis)  in  lysing  the  HLA  A3  +  B 
lymphoblastoid line Laz  156.  Anti-T3A,B and  anti-T8A both  markedly inhibit  CTL 
effector function of this  clone  (_<10% lysis), whereas  anti-T8c  and  anti-T12  do not. 
These results  are in keeping with  earlier studies which  indicated  that  both  anti-T3 
and anti-T8 monoclonal antibodies can inhibit T8  ÷ CTL (5, 8,  11). In addition, they 
are consistent with the finding that not all anti-T8 antibodies mediate this effect  (9, 
10).  More  importantly,  both  anti-TilA  and  anti-Tim  markedly  inhibit  the  CT8m 
clone's cytotoxic effector capacity (<20 and <5% specific lysis, respectively). Although 
it  is  not  shown,  the  fact  that  inhibitory  effects  of the  monoclonal  antibodies  were 
observed at dilutions of ascites varying from  1:250 to  1:2,500 and were evident after 
<30 rain of preincubation  with CTSm should be noted.  However, the magnitude of 
the inhibitory effect increased with the length of preincubation. 
Although  by indirect  immunofluorescence  anti-Tiaa  and  anti-Tim  reactivity  ap- 
peared to be restricted to the CTSm clone, we also determined whether the functional 
effects of these antibodies on cytolytic activity were restricted to CT8In. As shown in 
Table  I,  anti-TilA  and  anti-Tim  exclusively  inhibited  killing  of t-he  CT8m  clone 
among a  panel of five CTL clones tested.  In contrast, the effects of anti-T3, anti-T4, 710  HUMAN T  CELL  RECEPTORS  FOR ANTIGEN 
TABLE  I 
Inhibitory Effects of Monoclonal Antibodies on CML by Various T  Cell Clones 
Monoclonal antibody 
T cell clone 
CT4I  CT4II  CT8I  CT8n  CTSIII 
Anti-T3A.B  I +  +  +  +  +  I 
Anti-T4A  [+  +  I  -  -  - 
Anti  TSA   -  -  [+  +  +  I 
Anti-TiaA  ....  ~-~ 
Anti-Tim  .... 
Clonally restricted functional activity of anti-TiaA and anti-Tim.  Various  T 
cell clones, all cytotoxie for Laz 156 target cells, were incubated with mono- 
clonal antibodies  (final dilutions: anti-T3A, 1:300; anti-T3n,  1:500; anti-T8A, 
1:500; anti-T8B, l:500;  anti-T4A, l:500;  anti-TilA,  1:300; anti-Tim,  1:500) 
before incubation with 51Cr-labeled  Laz 156 cells at an E/T ratio of 20:1. +, 
inhibition of CML >60%; -, inhibition of CML <3%. 
Stimulus 
Medium 
IL-2 
Laz  156 
1L-2 plus Laz  I56 
TABLE  II 
Influences of Monoclonal Antibodies on Proliferative Responses of Clone CTSm 
Untreated  Anti-TilA  Anti-Tim  Anti-T31~  Anti-TSA  Anti-Tl2 
41 +  23  139 ~- 36  206 ±  54  92 ±  34  65 +  27  23 ±  20 
2,714 +  135  10,927  -+ 1,520  15,009 +  1,049  13,417  +  1,520  2,525 +  327  2,459 -I- 476 
12,295  ±  317  2,117 ±  438  1,169 ±  207  776 ±  99  11,756 ±  817  10,956 ±  357 
17,152±471  [4,399 ±  1,005  15,953:t:2,176  I5,739±l,377  15,389±2,I76  14,992±790 
Influence of various monoclonal antibodies on proliferative responses of CT8m to various stimuli. CT8m cells were incubated with monoclonal 
antibodies or media before assessment of their proliferative  responses. Final dilutions of monoclonal antibodies were: anti-Tit^,  1:300; anti- 
Tim, 1:500; anti-T3m I : 1,500;  anti-T8A, 1:500; anti-T12,  1:500.  Numbers are given as counts per minute of [3H]TdR and represent the means 
of triplicates. 
and anti-T8 antibodies were not  restricted to the CT8m  clone. Anti-T3 monoclonal 
antibodies  blocked  all  five  CTL  clones  irregardless  of  their  T4 +  or  T8 +  subset 
derivation or  specificity; anti-T4A inhibited  cytolysis by  the  T4 +  clones  CT4I  and 
CT4II and had no effect on killing by the T8 + clones CT8I, CT8II, and CT8m;  and in 
a  reciprocal fashion, anti-T8A and anti-T8B monoclonal antibodies inhibited killing 
of all three T8 ÷ CTL but not the two T4 CTL clones, CT4I and CT4II. 
Previous studies indicated that some human  CTL clones not only specifically kill 
target cells but also proliferate to them in an antigen-specific fashion (5). To examine 
the effect of the anti-clonotypic antibodies on the antigen-specific proliferative capac- 
ity of clone CT8m,  an  additional series of experiments was performed.  As shown  in 
Table II, untreated  CWSiii cells proliferate to both  IL-2-containing supernatants  as 
well as the allogeneic cell line Laz  156, to which they had been originally stimulated. 
Under these experimental conditions, antigen  (Laz  156)  is the stronger stimulus for 
CTSIII cell proliferation as judged by the greater [3H]TdR  incorporation into CT8III 
with  the former  (>12,000  cpm  vs.  2,714  cpm).  In  addition, the induction of clonal 
proliferation by the combination of alloantigen and IL-2 is greater than with either 
alone  (17,152  cpm).  Pretreatment  of CTSIII with  anti-Tiln  or  anti-Tim  markedly 
reduces antigen-specific proliferation of the CT8III clone. Thus, whereas the untreated 
CT8m  clone  proliferated  with  >t2,000  counts  of  [aH]TdR  to  Laz  156,  CT8m 
preincubated with anti-TilA or anti-Tim proliferated with <2,500  cpm, a  reduction MEUER ET AL.  711 
FIG. 3.  Modulation  and co-modulation  of CT8m surface structures by anti-T3B treatment. CT8III 
cells were incubated with the monoclonal  antibody anti-T3B (final dilution 1:300) for 18 h at 37°C 
and subsequently washed several times. Surface phenotype was determined by means of indirect 
immunofluorescence before (dark areas) and after (light areas) modulation with saturating concen- 
trations of monoelonal antibodies. Panel A: anti-T3B (1:300); panel B: anti-Tis^ (1:500); panel C: 
anti-Tim (1:500); panel D: anti-TSA (1:500). 
in proliferation of >80%. A similar reduction of proliferation was obtained with anti- 
T3B. That these effects were not simply due to an inactivation of the CT8Iu clone as 
a  result of antibody treatment  is clear from the fact that  (a)  anti-T 12 and anti-T8A 
have no inhibitory effects in this system (Table II); and  (b)  the anti-TilA, anti-Tim- 
or anti-T3B-treated  CT8m clone has  an  augmented  proliferative  capacity to  IL-2- 
containing supernatant (>10,000 cpm vs. <3,000 cpm). It should be emphasized that 
anti-TSA, in contrast to its ability to profoundly block cytolytic effector function by 
T8  + CTL clones, lacks any inhibitory effect on antigen-specific proliferation. 
The observation that anti-T3, anti-TilA, and anti-Tim all inhibited antigen-specific 
proliferation and CTL effector function and enhanced IL-2 responsiveness of CT8m 
suggested that there might be a relationship between the cell surface structures defined 
by these antibodies. In this regard, previous studies (5) indicated that binding of anti- 
T3  antibodies  to  T  cells  at  37°C  resulted  in  selective  modulation  and  external 
shedding of the  T3  molecular complex without  affecting cell  viability  or  altering 
expression of other known T  cell surface structures  including T1, Tll,  T12, or T8 
surface  molecules.  To  determine  whether  anti-T3  induced  modulation  produced 
changes in surface expression of detectable Til)~ or Tila molecules, CT8In cells  were 
first incubated with anti-T3B for 18 h at 37°C and washed to remove free monoclonal 
antibody; subsequently, cell reactivity was analyzed by indirect immunofluorescence 
on an Epics V  cell sorter with a panel of monoclonal antibodies. 
As shown in Fig. 3, before modulation, all CT8m cells were reactive with anti-T3A, 
anti-TixA,  anti-Tim,  and  anti-T8A  (panels  A-D,  dark  curves).  In  contrast,  after 
modulation with anti-T3a, T3 antigen was no longer detectable (panel A, light curve). 
More importantly, anti-T3B-induced modulation also resulted in loss of the anti-Ti~A 
and  anti-Tim surface epitopes  (panels  B  and  C,  respectively).  That  this  was not  a 
nonspecific effect is evident from the observation that the T8 antigen density (panel 712  HUMAN T  CELL RECEPTORS FOR ANTIGEN 
TABLE III 
Competitive Inhibition of Monoclonal Antibody Binding to Clone CTSIII 
1st incubation 
Anti-T3A  Anti-T3B  Anti-T8A  Anti-TilA  Anti-Tim 
2nd incubation 
[+  +]  -  -  Anti-T3A-FITC 
I 
+  + [  Anti-Tim-FITC 
+  +  Anti-Tim-FITC 
Competitive inhibition of monoclonal antibody binding to CT8m cells. 1st incubation: CT8nI cells 
were incubated for 30 min at 4°C with an unlabeled monoclonal antibody (final dilutions 1:100) 
and then washed twice in cold medium. 2nd incubation: to the antibody-treated CTS~I cells was 
added an FITC-labeled monoclonal antibody (final dilution 1:50) followed by analysis on an Epics 
V cell sorter. +, blocking of binding of FITC-labeled monoclonal antibodies as judged by reduced 
fluorescence (>90% reduction, on the basis of mean channel fluorescence as compared with CTSIn 
ceils pretreated with negative control ascites). -, unchanged fluorescence (<5% reduction). 
D) was not influenced by this process. Although not shown, incubation of CTSIII cells 
with either anti-TilA or anti-Tim had identical effects: in all cases T3, TilA, and Tim 
molecules co-modulated. The above results would indicate that the molecules defined 
by anti-T3,  anti-TilA,  and  anti-Tim  are  functionally  and  phenotypically linked  on 
the cell surface of this clone. 
To further investigate the relationship  of the epitope defined by anti-T3 and those 
defined  by  anti-TilA  and  anti-Tim,  both  competitive  antibody  binding  inhibition 
studies and immunoprecipitations were performed. As shown in Table III, unlabeled 
anti-T3A and  anti-T3~  inhibited  subsequent  binding of directly FITC-labeled  anti° 
T3A, whereas anti-TilA and anti-Tim did not. In a  reciprocal fashion, unlabeled anti- 
T3A or anti-T3B failed to inhibit  subsequent  binding of directly FITC-labeled anti- 
TiaA or anti-Tim.  In contrast,  either unlabeled  anti-Til  antibody was inhibitory  for 
FITC-labeled anti-TilA or anti-Tim. Under no circumstances did unlabeled anti-T8A 
block  binding  of  directly  FITC-labeled  anti-T3A,  anti-TilA,  or  anti-Tim.  Taken 
together,  these  findings would suggest  that  the surface epitopes  recognized by anti- 
TixA  and  anti-Tim  are  spacially  related  (or  identical)  to  one  another  but  clearly 
distinct  from those defined by anti-T3 or anti-T8 antibodies. 
To define biochemically the surface molecules detected by anti-TilA and anti-Tim, 
crsiii  cells were labeled by lactoperoxidase technique with 13~I and immunoprecipi- 
tates  from solubilized  membranes  subjected  to SDS-PAGE. As a  control, CTaIv, an 
additional  autologous T8 ÷ CTL clone nonreactive with anti-TilA and anti-Tim, was 
tested in parallel.  Fig. 4 shows that under reducing conditions, anti-Tim precipitated 
two distinct bands of ~49,000 and 43,000 mol wt, respectively, from the CT8III clone 
(channel  C),  but  not  the  irrelevant  cr8iv  clone  (channel  D).  In a  parallel  fashion, 
anti-Tim precipitated  identical structures  from the same CT8HI clone  (panel E), but 
not the irrelevant CT8iv clone (channel F). Negative control precipitates  from crsiii 
and CT8Iv using monoclonal antibody T6 are shown in channels A and B, respectively. 
Both  the  inability  of the  anti-clonotypic  antibodies  to  inhibit  anti-T3  cell  surface 
binding and the  present  biochemical  data  are consistent  with  the  notion that  these 
two sets of antibodies  are directed  at  different  glycoproteins than  the major 20,000- 
mol wt glycoprotein defined by anti-T3 antibodies. MEUER  ET  AL.  713 
FzG. 4.  SDS-PAGE  of immunoprecipitates  from  T  cell  clones  CT8m  and  CT8rv.  A:  anti-T6 
(CT8m); B: anti-T6 (CTSIv);  C: anti-Til^ (CT8m); D: anti-TilA (CT8tv); E: anti-Tim (CT8m); F: 
anti-Tim (CTSrv). 
Discussion 
In  the  present  study,  murine  monoclonal  antibodies  were  produced  against  a 
human  T3+T8  +  CTL  clone,  CTSm,  with  the  view  of defining  components  of its 
surface receptor structures for antigen. By first screening for reactivity on autologous 
B  lymphoblastoid cells and  other alloreactive clones using indirect  immunofluores- 
cence, antibodies to broadly distributed lymphoid lineage markers or allospecifieities 
were eliminated. Only 2 of 221 B-B hybridomas resulting from a single fusion between 
CT8m-immune BALB/cJ  splenocytes  and  NS-1  myeloma cells  secreted  antibodies 
that were restricted in their reactivity to CTSIII; these were termed anti-TilA and anti- 
TiIB. Anti-TiaA and  anti-Tim did not  react with  thymocytes, resting or activated T 
lymphocytes,  B  lymphocytes,  macrophages,  granulocytes,  platelets,  or  any  of  80 
additional  clones  from the  same individual  donor  as  the  CTSm clone.  In contrast, 
anti-T3,  anti-T4,  and  anti-T8  reacted  with  all  mature  T  lymphocytes,  inducer  T 
lymphocytes, and  suppressor T  lymphocytes, respectively (1,  2).  Moreover, all allo- 
reactive human  T  cell clones were T3  + and  expressed either  the  T4 or T8  surface 714  HUMAN T  CELL RECEPTORS  FOR ANTIGEN 
molecules.  Thus,  unlike  the  previously defined  antibodies,  anti-TiaA  and  anti-Til~ 
recognized clonotypic structures. 
Anti-TiaA and anti-Tim had striking effects on CTSm cell function: both inhibited 
its antigen-specific proliferative responses and CTL effector function. Because similar 
effects were observed with anti-T3 antibodies  (5-8,  11), we investigated the relation- 
ship  of TilA,  Tim, and T3  molecules in  greater detail.  It was  found  that  all  three 
surface structures were associated on CT8m because they co-modulated after binding 
either anti-TilA, anti-Tim, or anti-T3 antibodies. However, multiple lines of evidence 
indicated that these antibodies reacted with different surface epitopes: (a) the cellular 
distribution of anti-T3 reactivity was distinct  from anti-TiaA and anti-Tim, as noted 
above;  (b)  anti-T3  antibody blocked the killing function  of all CTL clones tested, 
whereas the effect of anti-TilA and anti-Tim was restricted to CT8m; (c) in competitive 
binding studies  with  FITC-labeled and unlabeled  antibodies,  neither  anti-TilA nor 
anti-Tim inhibited anti-T3 binding to CT8m cells and vice versa, whereas anti-TilA 
and/or anti-TilB inhibited each other's binding to CT8III; and (d) unlike anti-T3A or 
anti-T3B, which precipitated a  major 20,000-mol wt glycoprotein from all mature T 
cells and thymocytes (5, 22), anti-TilA and anti-Tim were found to immunoprecipitate 
two  bands  at  49,000  and  43,000  tool  wt  under  reducing  conditions  from the  ~3aI- 
radiolabeled CT8m clone alone. The specificity of anti-Ti~A and anti-Tim for epitopes 
unique to the CT8m clone was further supported by the absence of detectable material 
on SDS-PAGE analysis of immunoprecipitates from three other T8  + CTL clones and 
a heterogeneous T  cell population (predominantly T8  +) derived from the same donor 
as CT8m (Fig. 4 and data not shown). 
More recent studies  (5,  11)  have indicated that preincubation of clones with anti- 
T3 antibodies abrogated antigen-specific proliferation and CTL effector function of 
every population tested. After anti-T3 antibody surface binding at 37°C, the 20,000- 
mol wt T3 molecules were externally shed in a modulation process that required  18- 
24 h.  Loss of antigen-specific function  was evident when surface T3 was bound  by 
anti-T3 before modulation and persisted in the post-modulation period when neither 
surface antibody nor T3 molecules were detectable on the clone.  More importantly, 
after  anti-T3-induced  modulation,  CTL  recovered  effective  cytolytic  activity  in 
parallel with reexpression of surface T3 molecules (5). That this effect was not simply 
due  to  the  modulation  process  itself was  evident  from parallel  studies  in  which  a 
different antigen, T1, a 67,000-mol wt glycoprotein, was induced to modulate from T 
cell clones with anti-T1  antibody.  In that case, no inhibition of T  cell function was 
noted (5). Thus, both the appearance of T3 in late intrathymic ontogeny at the time 
of acquisition  of immunologic  competence  and  its  critical  role  in  T  lymphocyte 
function  (1,  4)  suggested  that  it  was  closely  linked  to  an  important  recognition 
receptor.  Hence, the  association of the  20,000-mol  wt T3 molecule with clonotypic 
structures  such  as TilA  and  Tim  involved  in  antigen  recognition  was  not  entirely 
unexpected. 
It is likely that anti-TilA and anti-Tim define variable regions of the human T  cell 
antigen  receptor on CT8m because they recognize clonotypic structures and inhibit 
antigen-specific function.  In contrast,  the wide distribution  within  the T  lineage of 
the 20,000-tool wt T3 glycoprotein defined by the presently existing anti-T3 antibodies 
suggests that,  unlike  anti-TiaA and  anti-TiaB,  they  define  a  constant  region  of the 
antigen  receptor  complex.  This  does  not  exclude  the  possibility,  however,  that MEUER  ET AL.  715 
variability could exist within another portion of this structure or that it might possess 
antigen  binding  properties.  In  this  regard,  it  is known  that  at  least  one other  25- 
28,000-mol wt structure is associated with the T3 molecular complex (22). Biochemical 
analysis at the protein and DNA level will resolve this issue. 
Two  major  subsets  of T  lymphocytes  have  been  defined  on  the  basis  of their 
differential expression of either the T4 or T8 surface molecules. These are glycoproteins 
of molecular weight 62,000 and  76,000,  respectively, which  are unrelated  to T3  (2). 
Although cytotoxic effector T  lymphocytes are derived from both of these populations, 
the target antigens they recognized are the products of different major histocompati- 
bility complex (MHC) gene regions (9,  12). Specifically, allosensitized T4  + T  cells kill 
class II MHC antigens, whereas T8  + T  cells kill class I MHC antigens. 
The  association  between  surface  phenotype  of a  CTL  and  the  class  of MHC 
molecule that it recognized implied that the same subset restricted structures might 
be required in the facilitation of selective lysis of target antigens. This hypothesis has 
now been substantiated  by the finding that monoclonal antibodies to the T4 or T8 
glycoproteins selectively inhibit cytolytic effector function of T4 or T8 clones, respec- 
tively. Because their inhibitory effects can be bypassed by agglutination of CTL and 
target cells with the lectin Con A, these structures are probably not involved in the 
lytic  mechanism  itself  (11,  23).  Similarly,  it  should  be  noted  that  Con  A  could 
reconstitute the capacity of the CT8m clone to kill the HLA-A3 alloantigen bearing 
target Laz 156, even in the presence of anti-T3, anti-TilA, or anti-Tim. However, in 
this case, killing specificity was lost because the CT8m clone killed HLA-A3 negative 
targets as well. 
The effects of anti-T4 and anti-T8 antibodies are clearly distinct from those of anti- 
T3, or in the case of the CT8m clone, anti-Ti~A or anti-Tim, in one major respect. The 
former two antibodies, unlike the latter three, do not block antigen-specific prolifer- 
ative responses by T  cell clones. This suggests that the T4 and T8 glycoproteins may 
serve as subset-restricted association structures for nonpolymorphic determinants on 
classes of MHC gene products that may be required for efficient E/T interaction in 
CML rather than as components of the T  cell antigen recognition receptor linked to 
T3, TilA, and Tim. 
The observation that anti-T3, anti-Ti~, or anti-Tim pretreatment of CT8nI cells 
enhanced  subsequent  IL-2 responsiveness is  important  for several  reasons.  First,  it 
provides strong evidence that the effects of these monoclonal antibodies on antigen- 
specific function were not due to trivial consequence of global diminution  in clonal 
activity.  Second,  it  suggests  that  in  this  one  respect,  the  monoclonal  antibodies 
triggered  the  clone  in  a  similar  fashion  to  specific  alloantigen  because  both  yield 
enhanced  IL-2 responsiveness. Whether the basis of this effect is due to induction  of 
endogenous  IL-2  secretion  by  the  CT8m  clone  itself,  or  alternatively,  enhanced 
sensitivity to IL-2, for example, by means of alterations  in  the number or state of 
IL-2 receptors, is currently under investigation. In this regard, it is known that both 
major human  T  cell subsets  produce  IL-2 upon  appropriate stimulation  (24).  Fur- 
thermore,  the above findings  may in part  account  for the mitogenic effect of anti- 
idiotypic heteroantisera on murine T  cell clones, as previously reported (25). 
Previous attempts to characterize T cell receptor molecules have been largely biased 
by the assumption that they share certain similarities with surface immunoglobulin 
on B lymphocytes (see ref. 26 for review). In fact, analysis ofT cell idiotypic structures 716  HUMAN T  CELL RECEPTORS FOR  ANTIGEN 
has used antisera generated to variable regions of secreted immunoglobulin. Although 
the  existence  of such  idiotypes on T  cells  has  been  suggested by a  multiplicity  of 
functional  studies  whereby antiidiotypes  produced  effects on  immunoregulatory T 
cell populations  (27-29),  the precise nature of the T  cell molecules defined by these 
antisera is still poorly understood.  Furthermore,  the  lack of easily demonstrable Ig 
gene rearrangements in homogeneous murine T  helper and T  suppressor lines with 
JH and CH gene probes (30,  31)  suggests that antigen  recognition by T  cells in all 
likelihood  does  not  occur through  structures  closely analogous  to  those  used  by B 
lymphocytes. 
The molecular weights of TitA and Tim in the human system appear to be strikingly 
similar to those  of antigen-specific suppressor  factors generated  in  a  J(enopus laevis 
oocyte translation system using messenger RNA from a  keyhole limpet hemocyanin- 
specific murine T-T hybridoma clone that consisted of two individual antigen binding 
molecules of molecular weights 29-30,000  and 45-62,000  (32,  33).  However, others 
(28,  34-48)  reported suppressor factors and antigen-binding material that appear to 
be of different molecular weight and characteristics. Whether the reported differences 
result  from the use of functionally distinct  T  cell  populations,  alterations  resulting 
from the  fusion  process in  the case of T-T hybridomas and/or  differences between 
secreted and surface forms of the T  cell receptor, is not known at the present time, but 
clearly, all possibilities remain open. 
The generation of monoclonal antibodies to cloned T cell populations may represent 
an advantageous approach to define T  cell surface recognition structures because it 
makes no assumptions about the similarities between B and T  cell receptor molecules. 
In  addition,  it  allows  for  the  development  of probes  to  the  cell  surface  receptor 
glycoproteins themselves as opposed to secreted antigen-specific products that may be 
significantly different from the intact membrane molecule. The use of cloned homo- 
geneous  T  cells  should  furthermore  provide  the  functional  machinery  to  identify 
important biologic effects of anti-clonotypic antibodies on the immune response and 
yield the cellular material for precise biochemical and genetic studies. 
Summary 
Monoclonal  antibodies  were  produced  against  a  human  cytotoxic T  cell  clone, 
CT81IX (specificity: HLA-A3), with the view of defining clonally restricted (clonotypic) 
surface molecules involved in its antigen recognition function. Two individual  anti- 
bodies, termed anti-TilA and anti-TilB, reacted exclusively with the CT8m clone when 
tested on a panel of 80 additional clones from the same donor, resting or activated T 
cells,  B  cells,  macrophages, thymocytes, or other  hematopoietic cells.  More  impor- 
tantly, the two antibodies inhibited cell-mediated killing and antigen-specific prolif- 
eration of the CTSIn clone but did not affect the functions of any other clone tested. 
This  inhibition  was  not  secondary  to  generalized  abrogation  of the  CTSIII clone's 
function,  because interleukin  2  responsiveness was enhanced.  To examine the rela- 
tionship  of the  structures  defined by anti-clonotypic antibodies  with  known  T  cell 
surface  molecules,  antibody-induced  modulation  studies  and  competitive  binding 
assays  were  performed.  The  results  indicated  that  the  clonotypic  structures  were 
associated with,  but  distinct  from, the  20,000-tool  wt T3 molecule expressed on all 
mature T  lymphocytes. Moreover, in contrast to anti-T3, anti-TilA and anti-TilB each 
immunoprecipitated  two  molecules  of 49,000  and  43,000-mol  wt  from  l~lI-labeled MEUER  ET  AL.  717 
CT8~I cells under reducing conditions. The development of monoclonal antibodies to 
such polymorphic T  cell surface structures should provide important probes to further 
define the surface receptor for antigen. 
Note added in proof." Since submission of this manuscript, we have produced an anti- 
clonotypic  monoclonal  antibody,  anti-Ti2A,  to  a  surface  structure  on  the 
T3+,T4+,T8-  class II-specific CTL clone CT4II. The Ti~  clonotype, like TiIA and 
Tim on  CTSm,  is membrane  associated with  T3.  As expected, anti-Ti~  selectively 
blocks antigen-specific proliferation and CTL effector function of CT4n and enhances 
its IL-2 responsiveness. 
The authors wish to thank Dr. Lan Bo Chen for thoughtful discussions and technical advice, 
and Mr. John Daley and Mr. Herbert Levine for performing cell-sorter analysis. 
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